13.07.2015 Views

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

For women diagnosed during 1993-2001 and irradiated thecardiac mortality ratio was 0.96 (0.82-1.12), with none yetfollowed <strong>for</strong> 10 years. Among women irradiated <strong>for</strong> breastcancer who subsequently developed an ipsilateral orcontralateral lung cancer, the lung cancer mortality ratio(ipsilateral versus contralateral) <strong>for</strong> women diagnosed during1973-82 and irradiated was 1.17 (0.62-2.19), 2.00 (1.00-4.00),and 2.71 (1.65-4.48), respectively, less than 10 years, 10-14years, and 15 or more years afterwards (trend: 2p=0.04). Forwomen irradiated after 1982 there is, as yet, little in<strong>for</strong>mationon lung cancer risks more than 10 years afterwards.INTERPRETATION: US breast cancer radiotherapy regimens<strong>of</strong> the 1970s and early 1980s appreciably increased mortalityfrom heart disease and lung cancer 10-20 years afterwardswith, as yet, little direct evidence on the hazards after morethan 20 years. Since the early 1980s, improvements inradiotherapy planning should have reduced such risks, but thelong-term hazards in the general populations <strong>of</strong> variouscountries still need to be monitored directly.Lancet. 2005 Dec 17;366(9503):2087-106.Effects <strong>of</strong> radiotherapy and <strong>of</strong> differences in the extent <strong>of</strong>surgery <strong>for</strong> early breast cancer on local recurrence and 15-year survival: an overview <strong>of</strong> the randomised trials.Clarke M, Collins R, Darby S, Davies C, Elphinstone P,Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnonE, McGale P, McHugh T, Peto R, Taylor C, Wang Y; EarlyBreast <strong>Cancer</strong> Trialists’ Collaborative Group (EBCTCG).Clinical Trial Service Unit, Ox<strong>for</strong>d, UK.BACKGROUND: In early breast cancer, variations in localtreatment that substantially affect the risk <strong>of</strong> locoregionalrecurrence could also affect long-term breast cancer mortality.To examine this relationship, collaborative meta-analyses were312

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!